Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Nicklas Westerholm — CEO

Roles

11.05.2026 – 13.05.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
13.05.2026Egetis Therapeutics AB (publ) Stockholm
SoldDisposal
286,071SEK 6.50
SEK 1,859,461.50
↗
11.05.2026Egetis Therapeutics AB (publ) Stockholm
Share award
529,761—
Share award
529,761 shares
↗